Home  /  Resource Library  /  Patients with Relapsed/Refractory Marginal Zone Lymphoma in the MAGNIFY Phase IIIb Interim Analysis of Induction R2 Followed By Maintenance

Patients with Relapsed/Refractory Marginal Zone Lymphoma in the MAGNIFY Phase IIIb Interim Analysis of Induction R2 Followed By Maintenance

ASH 2020: Results of a study investigating lenalidomide combined with rituximab for treatment of relapsed marginal zone lymphoma.